NOVARTIS AG
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Basic company information
Each field links to its source. Financial figures retain their reporting periods; background references are identified in the source list.
- Ticker / security symbols
- NVS, NVSEF [1]
- Listing exchanges
- NYSE, OTC [1]
- SEC industry
- Pharmaceutical Preparations [1]
- Business sectors
- chemical industry; pharmaceutical industry [2]
- Company / filing name
- NOVARTIS AG [1]
- Headquarters location
- Basel [2]
- Business address
- LICHTSTRASSE 35, BASEL, V8, CH 4056 [1]
- Founded
- 1996 [2]
- Legal form
- Aktiengesellschaft [2]
- Incorporation jurisdiction
- Switzerland [1]
- Leadership in background record
- Vasant Narasimhan [2]
- Official website
- www.novartis.com ↗ [2]
- Fiscal year end
- December 31 (SEC record) [1]
- ISIN (reported securities)
- CH0012005267 [2]
- CIK
- 0001114448 [1]
- SIC code
- 2834 [1]
- Country in background record
- Switzerland [2]
Company positioning and business
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024. [3]
Novartis manufactures the drugs clozapine (Clozaril), diclofenac (Voltaren; sold to GlaxoSmithKline in 2015 deal), carbamazepine (Tegretol), valsartan (Diovan), imatinib mesylate (Gleevec/Glivec), cyclosporine (Neoral/Sandimmune), letrozole (Femara), methylphenidate (Ritalin; produced by Sandoz since 2023), terbinafine (Lamisil), deferasirox (Exjade), and others. [3]
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes (new skills). [3]
Background text: Wikipedia contributors, Novartis. Selected introductory paragraphs, licensed under CC BY-SA 4.0. Official filing data is cited separately.
Management and corporate governance
The Wikidata background record identifies Vasant Narasimhan in the chief-executive role. This background entry is not an official confirmation of the current board or executive roster. [2]
Financial year, securities and disclosures
The SEC submissions record gives NOVARTIS AG a fiscal year end of 1231 (MMDD). Individual filings below identify their own reporting period; the filing date is the publication event, not the financial year end. [1]
Listed securities: NVS (NYSE), NVSEF (OTC). Multiple symbols may represent different share classes or securities of the same registrant. [4]
History and key events
Financial results and regulatory disclosures
Annual, quarterly and current reports from the collected SEC record. Insider Forms 4 and 144 are excluded. This is a selected list, not a live filing feed.
Source-verified relationships
Companies in the same industry
Comparison candidates share the SEC SIC classification 2834. This does not imply ownership, partnership or trading relationships.
Related entities and concepts
Frequently asked questions
When was NOVARTIS AG founded?
Founded: 1996. The linked source provides the background record. [2]
Where is the headquarters of NOVARTIS AG?
Headquarters location: Basel. The linked source provides the background record. [2]
Which business sectors are recorded for NOVARTIS AG?
Business sectors: chemical industry; pharmaceutical industry. The linked source provides the background record. [2]
NOVARTIS AG relationship map
Select a node to inspect its relationship and source.
3 verified direct relationships. Industry peers are not relationship edges.
Sources and review dates
- SEC — NOVARTIS AG filing identity and securities ↗
- Wikidata — company background record (CC0) ↗
- Wikipedia contributors — Novartis (CC BY-SA 4.0) ↗
- SEC securities directory ↗
- Company chronology / filing ↗
Reviewed 23 October 2026. Financial periods and historical event dates are shown separately. Figures reflect their stated source dates; this page is not a live quote or investment recommendation.